Author

Annalisa Lattanzi

Stanford MedicineORCID 0000-0002-3953-9172Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Daniel P. DeveriD· 1 shared Isabel Ojeda-Pérez· 1 shared Joab CamarenaiD· 1 shared Jose Carlos SegoviaiD· 1 shared José Luis López LorenzoiD· 1 shared Juan Antonio BuereniD· 1 shared Liwen XuiD· 1 shared Mark A. BehlkeiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Daniel P. DeverORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia

Sara Fañanas-Baquero, Oscar Quintana Bustamante, Daniel P. Dever, Omaira Alberquilla, Rebeca Sánchez‐Domínguez, Joab Camarena, Isabel Ojeda-Pérez, Mercedes Dessy-Rodríguez, Rolf Turk, Mollie S. Schubert, Annalisa Lattanzi, Liwen Xu, José Luis López Lorenzo, Paola Ilaria Bianchi, Juan Antonio Bueren, , Jose Carlos Segovia

This study uses gene editing in hematopoietic stem cells to treat Pyruvate Kinase Deficiency Hemolytic Anemia, restoring RPK function and ATP levels in erythroid cells.

Molecular Therapy — Methods & Clinical Development · May 13, 2021Peer-reviewedGenetics